Biomarin Pharmaceutical (BMRN) Total Non-Current Liabilities (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Total Non-Current Liabilities of $5.19 billion for Q2 2026, up 305.5% from $1.28 billion a year earlier and up 133.5% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical's Total Non-Current Liabilities came in at $1.36 billion, up 12.8% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- In prior years, Biomarin Pharmaceutical's Total Non-Current Liabilities was $1.2 billion in FY2024 (-32.1%), $1.77 billion in FY2023 (+5.9%), $1.67 billion in FY2022 (+1.9%) and $1.64 billion in FY2021 (+0.5%).
- The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities in data going back to Q4 2009.
- On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last four quarters, with growth averaging 37.4% over the last eight quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2026, with growth of 305.5%; the weakest was Q4 2024, with a decline of 32.1%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $2.22 billion (Q1 2026), $1.36 billion (Q4 2025) and $1.4 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.19 Bn | 1,101.77 Bn | 19.71 Bn | 60.66 Bn |
| 2 | Johnson & Johnson | 616.03 Bn | 534.56 Bn | 17.26 Bn | 105.50 Bn |
| 3 | AbbVie | 501.09 Bn | 474.20 Bn | 12.70 Bn | 106.45 Bn |
| 4 | Merck | 366.82 Bn | 321.20 Bn | 12.21 Bn | 80.25 Bn |
| 5 | Novartis Ag | 297.82 Bn | 261.81 Bn | 11.24 Bn | 48.34 Bn |
| 6 | Astrazeneca | 261.33 Bn | 235.02 Bn | 12.86 Bn | 33.91 Bn |
| 7 | Amgen | 235.89 Bn | 191.29 Bn | 7.24 Bn | 78.66 Bn |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 35.10 Bn |
| 9 | Pfizer | 169.32 Bn | 115.96 Bn | 10.94 Bn | 97.04 Bn |
| 10 | Biomarin Pharmaceutical | 10.79 Bn | 4.66 Bn | 786.91 Mn | 5.19 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.19 Bn |
| Mar 31, 2026 | 2.22 Bn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.40 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.22 Bn |
| Dec 31, 2024 | 1.20 Bn |
| Sep 30, 2024 | 1.31 Bn |
| Jun 30, 2024 | 1.66 Bn |
| Mar 31, 2024 | 1.68 Bn |
| Dec 31, 2023 | 1.77 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 1.68 Bn |
| Mar 31, 2023 | 1.68 Bn |
| Dec 31, 2022 | 1.67 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.55 Bn |
| Mar 31, 2022 | 1.58 Bn |
| Dec 31, 2021 | 1.63 Bn |
| Sep 30, 2021 | 1.53 Bn |
API Access
Biomarin Pharmaceutical Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();